Home Bancorp (HBCP) Officer Reports 1,000-Share Purchase and Equity Awards
Rhea-AI Filing Summary
Natalie B. Lemoine, SEVP and Chief Administrative Officer of Home Bancorp, Inc. (HBCP), reported an open-market purchase of 1,000 shares of the issuer's common stock on 08/20/2025 at $26.81 per share, increasing her direct holdings to 6,314 shares. The filing also reports indirect ownership of 1,451.073 shares held via an ESOP. The Form 4 lists multiple outstanding employee stock options and restricted stock unit grants: several options covering 400–500 shares each and one 1,000-share option, with exercise prices ranging from $21.99 to $45.12 and various vesting schedules; restricted stock units totaling multiple grants that vest in 20% annual installments beginning on specified dates. The report is limited to changes in beneficial ownership and security awards and does not include company financial results.
Positive
- Insider purchase documented: Reporting person acquired 1,000 shares at $26.81 on 08/20/2025, increasing direct ownership to 6,314 shares.
- Transparency in awards: Filing provides detailed schedules for multiple RSU grants and option vesting dates, clarifying future dilution/timing.
Negative
- Outstanding dilution potential: Multiple unvested RSUs and employee stock options remain outstanding, which could dilute existing shareholders when settled.
- No materiality context: The filing does not provide company financial metrics, so the economic significance of the purchase relative to total holdings or company market cap is not shown.
Insights
TL;DR: Insider purchased 1,000 HBCP shares at $26.81 and holds both direct and ESOP-linked indirect positions; multiple outstanding options and RSUs remain.
The reported buy is a modest open-market purchase that raises direct ownership to 6,314 shares and confirms 1,451.073 shares held indirectly in an ESOP. The filing details numerous employee stock options with exercise prices from $21.99 to $45.12 and scheduled vesting, plus multiple RSU grants that vest 20% annually. For investors, this filing documents insider accumulation and the executive's compensation mix of equity and deferred awards; the amounts are disclosed but not large relative to typical institutional holdings. No financial performance data or material corporate actions are included.
TL;DR: The Form 4 discloses routine insider purchase and standard equity compensation vesting schedules—no governance red flags shown.
The reporting person is an officer and director, and the Form 4 transparently lists both direct purchases and the structure of outstanding equity awards, including RSUs and options with multi-year vesting. Vesting commencement dates and remaining unvested RSUs are specified for several grants, which is consistent with retention-style executive compensation. The filing contains required signatures and explanations; it does not disclose any departures, policy changes, or unusual transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 1,000 | $0.00 | -- |
| Exercise | Common Stock | 1,000 | $26.81 | $27K |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes the grant of 1250 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock. Includes the grant of 250 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 100 restricted stock units remain unvested. Includes the grant of 750 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 450 restricted stock units remain unvested. Includes the grant of 800 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 640 restricted stock units remain unvested. Includes the grant of 1391 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026, and that may be settled only in shares of the Issuer's common stock. The options vest and become exercisable in five equal installments beginning May 23, 2017 The options vest and become exercisable in five equal installments beginning May 12, 2018. The options vest and become exercisable in five equal installments beginning May 23, 2019. The options vest and become exercisable in five equal installments beginning May 23, 2020 The options vest and become exercisable in five equal installments beginning May 12, 2022. The options vest and become exercisable in five equal installments beginning March 12, 2021. The options vest and become exercisable in five equal installments beginning January 12, 2017
